How to select the most valuable anticancer drugs for reimbursement? Experience of ESMO and WHO
Summary. The constant appearance of new drugs for the treatment of oncological diseases and the need for the effective distribution of funds allocated for their purchase necessitates the search for a system of priorities and a methodology for the selection of drugs in order to maximize the positive effect.
Leave a comment